LOVENOX Safety Questions, LOVENOX Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LOVENOX. Our extensive database of LOVENOX adverse events and LOVENOX warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LOVENOX

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



LOVENOX Safety Reports

Total LOVENOX reports: 288.
LOVENOX FDA safety alerts: 2002 2004 .
Reported deaths: 67    Reported hospitalizations: 141.
Take LOVENOX Side Effects Survey or Share Your LOVENOX Story. LOVENOX Usage.

Showing 1-75 of 288 Next >

Consumer or non-health professional from reported LOVENOX problem on Apr 02, 2007. Female patient, 80 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiac failure, muscle haemorrhage, renal failure acute. LOVENOX dosage: unknown. During the same period patient was treated with PLAVIX, PREVISCAN, HEPARINE CHOAY, TARDYFERON. Patient was hospitalized. Patient died on 12/29/2006.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on Apr 10, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, respiratory distress. LOVENOX dosage: unknown. Patient died.

Consumer or non-health professional from reported LOVENOX problem on Apr 03, 2007. Female patient, 84 years of age, was diagnosed with atrial fibrillation and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: bladder distension, blood alkaline phosphatase increased, blood potassium decreased, coma, haematoma, haemoglobin decreased, hypotension, hypovolaemia. LOVENOX dosage: unknown. During the same period patient was treated with PREVISCAN, CORDARONE, LASILIX, DIFFU K. Patient died on 02/01/2007.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on Mar 30, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder. LOVENOX dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LOVENOX problem on Apr 16, 2007. Male patient, 84 years of age, weighting 224.9 lb, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: abdominal haematoma. LOVENOX dosage: 90 MG SQ BID. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on Apr 17, 2007. Female patient, 84 years of age, weighting 188.0 lb, was diagnosed with deep vein thrombosis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, renal failure acute, retroperitoneal haematoma. LOVENOX dosage: 80 MG Q 12 H. During the same period patient was treated with WARFARIN, AMIODARONE, TOPROL, PROTONIX, ASPIRIN, LIPITOR, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on Apr 17, 2007. Female patient, 80 years of age, weighting 182.0 lb, was diagnosed with deep vein thrombosis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: hypotension, loss of consciousness, retroperitoneal haemorrhage. LOVENOX dosage: 80 MG SC Q 12 H. During the same period patient was treated with PREVACID, ASPIRIN, TAMOXIFEN CITRATE, MIRAPEX, FUROSEMIDE, ALDACTONE, PREDNISONE. Patient died on 03/29/2007.

LOVENOX problem was reported by a Consumer or non-health professional from on Apr 16, 2007. Male patient, 78 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, blood fibrinogen increased, blood sodium decreased, cardiac failure, coagulation time prolonged, haematoma, haemodialysis, hyperkalaemia. LOVENOX dosage: unknown. During the same period patient was treated with PREVISCAN, AUGMENTIN, ALLOPURINOL, LASILIX, DIGITALINE NATIVELLE, OROCAL D, BRICANYL, ATROVENT. Patient recovered.

Physician from UNITED STATES reported LOVENOX problem on Apr 25, 2007. Male patient, 57 years of age, weighting 447.5 lb, was diagnosed with atrial fibrillation, cardioversion and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: abdominal wall disorder, haematoma, shock. LOVENOX dosage: 200 MG Q12H SQ. During the same period patient was treated with COUMADIN, AMIODARONE, COREG, PROZAC, IMDUR, ALLOPURINOL, APRESOLNE. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on Apr 24, 2007. Female patient, 18 years of age, weighting 169.8 lb, was diagnosed with deep vein thrombosis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: condition aggravated, deep vein thrombosis, dyspnoea, muscle spasms, pregnancy. LOVENOX dosage: unknown. During the same period patient was treated with DARVOCET, TYLENOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LOVENOX problem on Apr 24, 2007. Male patient, 29 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: peripheral ischaemia, thrombocytopenia. LOVENOX dosage: unknown. During the same period patient was treated with HEPARINE CHOAY, CALCIPARINE, CISPLATIN, GEMZAR. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on Apr 27, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: skin necrosis. LOVENOX dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LOVENOX problem on Apr 26, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, thrombosis. LOVENOX dosage: unknown. During the same period patient was treated with INTEGRILIN, ANTITHROMBOTIC AGENTS. Patient died on 04/01/2007.

LOVENOX problem was reported by a Health Professional from UNITED STATES on Apr 26, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, coronary artery thrombosis. LOVENOX dosage: unknown. During the same period patient was treated with INTEGRILIN. Patient died.

Consumer or non-health professional from reported LOVENOX problem on May 07, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant. LOVENOX dosage: unknown. Patient died.

LOVENOX problem was reported by a Physician from UNITED STATES on May 14, 2007. Female patient, 87 years of age, weighting 130.1 lb, was diagnosed with atrial fibrillation and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: asthenia, paraplegia, spinal haematoma, subdural haematoma. LOVENOX dosage: 60MG Q12H SC. During the same period patient was treated with COUMADIN. Patient recovered.

Consumer or non-health professional from reported LOVENOX problem on May 10, 2007. Male patient, 54 years of age, was diagnosed with hiv infection and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, leukopenia, thrombocytopenia. LOVENOX dosage: unknown. During the same period patient was treated with NORVIR, REYATAZ, TRUVADA, NEURONTIN, BACTRIM, NEUPOGEN. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on May 10, 2007. Female patient, 44 years of age, was diagnosed with pulmonary embolism and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: hepatitis, vascular purpura, venous thrombosis limb. LOVENOX dosage: unknown. During the same period patient was treated with PREVISCAN, ARIXTRA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LOVENOX problem on May 10, 2007. Male patient, 29 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: peripheral ischaemia, thrombocytopenia. LOVENOX dosage: unknown. During the same period patient was treated with HEPARINE CHOAY, CALCIPARINE, CISPLATIN, GEMZAR. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Physician from UNITED STATES on May 16, 2007. Female patient, 32 years of age, weighting 385.8 lb, was diagnosed with pulmonary embolism and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: intentional overdose, suicide attempt. LOVENOX dosage: unknown. During the same period patient was treated with ADVAIR DISKUS, ALBUTEROL, POTASSIUM ACETATE, GEODON, LEXAPRO, MIRENA, PREVACID, SENOKOT. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on May 22, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: septic shock. LOVENOX dosage: unknown. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2007. Female patient, 31 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. LOVENOX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOVENOX problem on May 23, 2007. Female patient, 31 years of age, weighting 280.6 lb, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, swelling. LOVENOX dosage: unknown. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on May 29, 2007. Female patient, 81 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, gastritis. LOVENOX dosage: unknown. During the same period patient was treated with KARDEGIC, PLAVIX, TENORMIN, AUGMENTIN, OFLOCET, NEBILOX, TRAMADOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LOVENOX problem on June 01, 2007. Male patient, 72 years of age, weighting 220.5 lb, was diagnosed with septic shock and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. LOVENOX dosage: unknown. During the same period patient was treated with CIFLOX, ROCEPHIN, TRIFLUCAN, ROVALCYTE. Patient died on 03/14/2007.

LOVENOX problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Male patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm. LOVENOX dosage: unknown. Patient died.

Consumer or non-health professional from reported LOVENOX problem on June 05, 2007. Female patient, 38 years of age, weighting 180.8 lb, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: chills, cyanosis, pyrexia, sepsis. LOVENOX dosage: unknown. During the same period patient was treated with VENOFER, PERFALGAN. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on June 05, 2007. Male patient, 80 years of age, was diagnosed with thrombosis prophylaxis, pneumococcal infection, guillain-barre syndrome, acute myocardial infarction, cardiomyopathy, sleep disorder and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: renal failure acute. LOVENOX dosage: unknown. During the same period patient was treated with AUGMENTIN, TEGELINE, KARDEGIC, SOPROL, ZOLPIDEM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LOVENOX problem on May 29, 2007. Female patient, 66 years of age, weighting 185.2 lb, was diagnosed with acute coronary syndrome and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: hepatitis, hepatocellular damage, thrombocytopenia. LOVENOX dosage: unknown. During the same period patient was treated with PLAVIX, TAHOR, TENORMIN, RAMIPRIL, HUMALOG, INSULATARD. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Health Professional from UNITED STATES on June 04, 2007. Female patient was treated with LOVENOX. LOVENOX dosage: unknown. Patient died.

Physician from UNITED STATES reported LOVENOX problem on June 04, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: retroperitoneal haemorrhage. LOVENOX dosage: unknown. Patient died.

LOVENOX problem was reported by a Consumer or non-health professional from on June 11, 2007. Male patient, 78 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, haematoma, hyperkalaemia, renal failure acute. LOVENOX dosage: unknown. During the same period patient was treated with PREVISCAN, AUGMENTIN, ALLOPURINOL, LASILIX, DIGITALINE NATIVELLE, OROCAL D, BRICANYL. Patient died on 04/24/2007.

Consumer or non-health professional from UNITED STATES reported LOVENOX problem on June 18, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. LOVENOX dosage: unknown. During the same period patient was treated with MEDITECH SYSTEM. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, haemorrhage, platelet count decreased. LOVENOX dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported LOVENOX problem on June 21, 2007. Female patient, 86 years of age, was diagnosed with prophylaxis, pulmonary embolism, thrombosis prophylaxis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: haematoma, paraplegia, post procedural complication. LOVENOX dosage: 30 MG 6H POST SPINAL SQ. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on June 18, 2007. Female patient, 74 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: agranulocytosis. LOVENOX dosage: unknown. During the same period patient was treated with SELOKEN, CIFLOX, ROCEPHIN, SKENAN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on June 21, 2007. Female patient, weighting 198.4 lb, was diagnosed with atrial fibrillation and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: injection site haematoma, muscle haemorrhage. LOVENOX dosage: 90MG Q12H SQ. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Physician from UNITED STATES on June 13, 2007. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anuria, cardiac arrest, injection site bruising, renal failure, retroperitoneal haemorrhage. LOVENOX dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on June 20, 2007. Female patient, 59 years of age, was diagnosed with prophylaxis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: renal failure acute, thrombosis. LOVENOX dosage: unknown. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on June 29, 2006. Female patient, 79 years of age, weighting 154.3 lb, was diagnosed with phlebitis superficial and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, epidermolysis, muscle haemorrhage, pain, skin necrosis. LOVENOX dosage: unknown. During the same period patient was treated with PREVISCAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LOVENOX problem on June 29, 2006. Male patient, 77 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: cauda equina syndrome, extradural haematoma. LOVENOX dosage: unknown. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on July 07, 2006. Female patient, 79 years of age, weighting 141.1 lb, was diagnosed with deep vein thrombosis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: cerebral disorder, confusional state, intraventricular haemorrhage, loss of consciousness. LOVENOX dosage: 60MG Q24HR SQ. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on July 10, 2006. Female patient, 59 years of age, weighting 225.5 lb, was diagnosed with deep vein thrombosis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: arthralgia, deep vein thrombosis, injection site bruising, injection site erythema, international normalised ratio abnormal, meniscus lesion. LOVENOX dosage: 100 MG BID SQ. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on July 04, 2006. Male patient, 58 years of age, weighting 121.3 lb, was diagnosed with anaesthesia, aspergillosis, hypertension and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: renal failure acute. LOVENOX dosage: unknown. During the same period patient was treated with RAPIFEN, CLAVENTIN, FUNGIZONE, CATAPRES, PLAVIX, PRAVASTATIN, AMLOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LOVENOX problem on June 29, 2006. Male patient, 58 years of age, weighting 121.3 lb, was diagnosed with anaesthesia, aspergillosis, hypertension and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, cytolytic hepatitis, gastrointestinal haemorrhage, melaena, renal failure acute. LOVENOX dosage: unknown. During the same period patient was treated with RAPIFEN, CLAVENTIN, FUNGIZONE, CATAPRES, PLAVIX, PRAVASTATIN, AMLOR. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on July 10, 2006. Male patient, 72 years of age, was diagnosed with thrombosis prophylaxis, hip arthroplasty, aortic arteriosclerosis, diabetes mellitus, hypercholesterolaemia, hypertension and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, diverticulum intestinal, hypovolaemia, rectal haemorrhage, renal failure acute. LOVENOX dosage: unknown. During the same period patient was treated with ASPIRIN, GLUCOPHAGE, PRAVASTATIN, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LOVENOX problem on June 24, 1998. Female patient, 73 years of age, was diagnosed with thrombosis prophylaxis, diabetes mellitus, mycobacteria urine test positive, hypertension and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, encephalopathy, haemolysis, renal failure acute. LOVENOX dosage: unknown. During the same period patient was treated with DIAMICRON, RIFATER, MYAMBUTOL, COZAAR. Patient died on 05/16/1998.

LOVENOX problem was reported by a Physician from UNITED STATES on May 02, 2006. Female patient, weighting 120.2 lb, was diagnosed with prophylaxis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: headache, intracranial hypotension. LOVENOX dosage: unknown. During the same period patient was treated with MORPHINE, EPIDURAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOVENOX problem on July 12, 2006. Female patient, 65 years of age, weighting 195.3 lb, was diagnosed with pulmonary embolism and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: haematoma, malaise, oedema, pulmonary oedema, renal failure. LOVENOX dosage: unknown. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on July 19, 2006. Female patient, 67 years of age, weighting 123.5 lb, was diagnosed with deep vein thrombosis, prophylaxis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia, platelet count decreased. LOVENOX dosage: 30 MG QNOON SQ 40MG QNOON SQ. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on July 20, 2006. Female patient, 78 years of age, weighting 219.0 lb, was diagnosed with thrombosis prophylaxis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaesthetic complication, extradural haematoma, paralysis, post procedural complication. LOVENOX dosage: 30 MG OTO SUBCUT. During the same period patient was treated with FENTANYL, BUPIVACAINE. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on July 19, 2006. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, cerebral palsy, convulsion, deafness bilateral, hypoxia, intraventricular haemorrhage. LOVENOX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOVENOX problem on July 19, 2006. Female patient was treated with LOVENOX. LOVENOX dosage: unknown. Patient died.

LOVENOX problem was reported by a Physician from UNITED STATES on July 25, 2006. Female patient, weighting 200.6 lb, was diagnosed with pulmonary embolism, cardiac failure congestive, chronic obstructive pulmonary disease and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiogenic shock, haemoglobin decreased, muscle haemorrhage. LOVENOX dosage: unknown. Patient was hospitalized. Patient died on 07/24/2006.

Consumer or non-health professional from reported LOVENOX problem on July 25, 2006. Male patient, 83 years of age, weighting 132.3 lb, was diagnosed with essential hypertension and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: thrombocythaemia. LOVENOX dosage: unknown. During the same period patient was treated with APROVEL, FLUDEX, LIBRAX, SPASFON, TRIMEBUTINE, LANZOR, TEMESTA, ISKEDYLT. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on July 25, 2006. Female patient, 82 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: anaemia, coagulopathy, melaena. LOVENOX dosage: unknown. During the same period patient was treated with ASPIRIN, PLAVIX, PREVISCAN, ATORVASTATIN CALCIUM, COVERSYL, PANTOPRAZOLE. Patient recovered.

Physician from UNITED STATES reported LOVENOX problem on July 26, 2006. Female patient was diagnosed with hypercoagulation and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. LOVENOX dosage: unknown. Patient recovered.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on Oct 25, 2005. Male patient, 60 years of age, weighting 149.9 lb, was diagnosed with immobile, pancreatic carcinoma and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: burning sensation, discomfort, refusal of treatment by patient. LOVENOX dosage: unknown. Patient died on 10/01/2005.

Physician from UNITED STATES reported LOVENOX problem on July 26, 2006. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: spinal haematoma. LOVENOX dosage: unknown. Patient recovered.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on Aug 01, 2006. Male patient, 41 years of age, weighting 187.2 lb, was diagnosed with thrombosis prophylaxis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alcohol withdrawal syndrome, antibody test positive, blood alcohol increased, diabetic ketoacidosis, electrolyte imbalance, gastric varices, heparin-induced thrombocytopenia test, hepatic failure. LOVENOX dosage: 40 MG DAILY SQ. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on Aug 07, 2006. Female patient, 61 years of age, weighting 239.9 lb, was diagnosed with pulmonary embolism and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: muscle haemorrhage, respiratory failure. LOVENOX dosage: 100MG Q12H SC. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on Aug 08, 2006. Female patient, 57 years of age, weighting 132.3 lb, was diagnosed with deep vein thrombosis, pulmonary embolism and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, haematocrit decreased, haematoma, haemoglobin decreased, platelet count decreased. LOVENOX dosage: 60 MG Q12 HOURS SQ. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOVENOX problem on Sept 21, 2001. Female patient, weighting 355.7 lb, was diagnosed with surgery and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, bloody discharge, enterocutaneous fistula, haematocrit decreased, hypotension, peritoneal haemorrhage, postoperative wound infection, tachycardia. LOVENOX dosage: unknown. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on Aug 03, 2006. Female patient, 85 years of age, was diagnosed with thrombosis prophylaxis, humerus fracture, hypothyroidism, venous insufficiency, hypercholesterolaemia and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: pancytopenia. LOVENOX dosage: unknown. During the same period patient was treated with TRIMETAZIDINE, LEVOTHYROXINE, MONICOR LP, ETIOVEN, FENOFIBRATE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on Aug 10, 2006. Female patient, 46 years of age, weighting 198.4 lb, was diagnosed with deep vein thrombosis, pulmonary embolism and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: ovarian abscess, pelvic haemorrhage, post procedural haemorrhage. LOVENOX dosage: 90 MG Q 12 H SQ. During the same period patient was treated with WELLBUTRIN, FAMOTIDINE, TPN, FLUOXETINE, HYDROMORPHONE. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from on Aug 03, 2006. Female patient, 41 years of age, weighting 149.9 lb, was diagnosed with thrombosis prophylaxis and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, chest pain, cold sweat, feeling hot, gamma-glutamyltransferase increased, headache. LOVENOX dosage: unknown. During the same period patient was treated with INNOHEP, DIPRIVAN, DESFLURANE, SUFENTA, MORPHINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on Aug 11, 2006. Male patient, 57 years of age, weighting 198.4 lb, was diagnosed with deep vein thrombosis, pulmonary embolism and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, pulmonary embolism. LOVENOX dosage: 90MG Q12H SQ. During the same period patient was treated with AMLODIPINE, LISINOPRIL, PANTOPRAZOLE, HYDROMORPHONE. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Female patient, 48 years of age, was diagnosed with antiphospholipid syndrome and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: cardiac enzymes increased, chest pain, intracardiac thrombus, visual disturbance. LOVENOX dosage: unknown. During the same period patient was treated with COUMADIN, METOPROLOL TARTRATE, VALTREX. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LOVENOX problem on Aug 11, 2006. Male patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. LOVENOX dosage: unknown. Patient died.

LOVENOX problem was reported by a Pharmacist from FRANCE on Aug 11, 2006. Male patient, 51 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: thrombocythaemia. LOVENOX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOVENOX problem on Aug 11, 2006. Female patient, 48 years of age, was diagnosed with antiphospholipid syndrome and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: cardiac enzymes increased, chest pain, intracardiac thrombus. LOVENOX dosage: unknown. During the same period patient was treated with COUMADIN, METOPROLOL, VALTREX. Patient was hospitalized. Patient recovered.

LOVENOX problem was reported by a Physician from UNITED STATES on Aug 09, 2006. Female patient, 35 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: coma, subarachnoid haemorrhage, subdural haematoma. LOVENOX dosage: unknown. During the same period patient was treated with NSAID. Patient recovered.

Health Professional from UNITED STATES reported LOVENOX problem on Aug 18, 2006. Female patient, 49 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: accidental needle stick. LOVENOX dosage: unknown. Patient recovered.

LOVENOX problem was reported by a Pharmacist from UNITED STATES on Aug 18, 2006. Female patient, 91 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal. LOVENOX dosage: unknown. Patient died on 08/01/2006.

Health Professional from UNITED STATES reported LOVENOX problem on Aug 16, 2006. Female patient, weighting 325.7 lb, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: injection site haematoma, international normalised ratio increased. LOVENOX dosage: unknown. During the same period patient was treated with COUMADIN, SYNTHROID, ATENOLOL, AVANDIA, ANTIDEPRESSANTS, ADVAIR DISKUS. Patient recovered.

Showing 1-75 of 288 Next >

Ask Our Patient Community about LOVENOX

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal